Shoppers Drug Mart (FRA:SDZ) EBIT : €623 Mil (TTM As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Shoppers Drug Mart EBIT?

Shoppers Drug Mart's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2013 was €164 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2013 was €623 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shoppers Drug Mart's annualized ROC % for the quarter that ended in Dec. 2013 was 11.24%. Shoppers Drug Mart's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2013 was 30.49%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shoppers Drug Mart's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2013 was 7.82%.

Shoppers Drug Mart EBIT Historical Data

The historical data trend for Shoppers Drug Mart's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shoppers Drug Mart EBIT Chart

Shoppers Drug Mart Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

EBIT

Get a 7-Day Free Trial

583.09

672.93

676.11

592.17

Shoppers Drug Mart Quarterly Data
	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13
EBIT	Get a 7-Day Free Trial															191.89	131.71	155.79	171.76	163.85

Competitive Comparison of Shoppers Drug Mart's EBIT

For the Pharmaceutical Retailers subindustry, Shoppers Drug Mart's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shoppers Drug Mart's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shoppers Drug Mart's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shoppers Drug Mart's EV-to-EBIT falls into.

Shoppers Drug Mart EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €623 Mil.

Shoppers Drug Mart (FRA:SDZ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shoppers Drug Mart's annualized ROC % for the quarter that ended in Dec. 2013 is calculated as:

	ROC % (Q: Dec. 2013 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2013 )	+	Invested Capital (Q: Dec. 2013 ))	/ count )
=	655.408 * ( 1 - 25.5% )	/	( (4435.983	+	4254.697)	/ 2 )
=	488.27896	/	4345.34
=	11.24 %

where

	Invested Capital		(Q: Sep. 2013 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5414.127	-	943.54	-	( 34.604	-	max(0, 1481.432	-	2048.831	+	34.604	))
=	4435.983

	Invested Capital		(Q: Dec. 2013 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5231.807	-	931.625	-	( 45.485	-	max(0, 1416.794	-	2022.466	+	45.485	))
=	4254.697

Note: The Operating Income data used here is four times the quarterly (Dec. 2013) data.

2. Joel Greenblatt's definition of Return on Capital:

Shoppers Drug Mart's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2013 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2013 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2013		Q: Dec. 2013
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	655.408	/	( ( (1192.732 + max(1064.833, 0))	+	(1128.27 + max(913.973, 0)) )	/	2 )
=	655.408	/	( ( 2257.565	+	2042.243 )	/	2 )
=	655.408	/	2149.904
=	30.49 %

where Working Capital is:

	Working Capital		(Q: Sep. 2013 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(367.333	+	1595.529	+	51.365)	-	(943.54	+	0	+	5.854)
=	1064.833

	Working Capital		(Q: Dec. 2013 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(370.614	+	1577.756	+	28.611)	-	(931.625	+	0	+	131.383)
=	913.973

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2013) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shoppers Drug Mart's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2013 )
	=	623.114	/	7970.014
	=	7.82 %

Shoppers Drug Mart EBIT Related Terms

Thank you for viewing the detailed overview of Shoppers Drug Mart's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Shoppers Drug Mart (FRA:SDZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shoppers Drug Mart Corporation (FRA:SDZ) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shoppersdrugmart.ca

Shoppers Drug Mart Corporation was founded in 1962. The Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in QuÃ©bec). The stores are owned and operated by the Company's licensed Associate-owners who have helped build a brand that is synonymous with exceptional service, value and trust. The Company also licenses or owns more than 55 medical clinic pharmacies operating under the name Shoppers Simply Pharmacy (Pharmaprix Simplement SantÃ© in QuÃ©bec) and six luxury beauty destinations operating as Murale. The Company owns and operates 62 Shoppers Home Health Care stores, which are engaged in the sale and service of assisted-living devices, medical equipment, home-care products and durable mobility equipment to institutional and retail customers. In addition to its retail store network, the Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of specialty drug distribution, pharmacy and comprehensive patient support services, and MediSystem Technologies Inc., a provider of pharmaceutical products and services to long-term care facilities.

Shoppers Drug Mart (FRA:SDZ) Headlines

No Headlines